Main menu

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease


The immune mechanisms responsible for the protection provided by Oxford-AstraZeneca’s COVID-19 vaccine are still unclear, but are important to understand for future vaccine development. The authors revealed distinct immune responses between vaccinated individuals and placebo recipients, through nanopore transcriptome sequencing. These differences provide a mechanistic understanding to how the vaccine reduces disease severity, and highlight biomarkers for future vaccine research.

Authors: Ruth E. Drury, Susana Camara, Irina Chelysheva, Sagida Bibi, Katherine Sanders, Salle Felle, Katherine Emary, Daniel Phillips, Merryn Voysey, Daniela M. Ferreira, Paul Klenerman, Sarah C. Gilbert, Teresa Lambe, Andrew J. Pollard & Daniel O’Connor

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag